Adverse event profile of fondaparinux sodium: a disproportionality analysis based on FAERS, JADER, and VigiAccess databases
BackgroundFondaparinux sodium, a synthetic pentose sugar, selectively inhibits factor Xa and is mainly used to prevent venous thromboembolism during major lower extremity orthopedic surgeries. It is also utilized for treating unstable angina pectoris and non-ST-segment-elevation myocardial infarctio...
Tallennettuna:
| Päätekijät: | , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Frontiers Media S.A.
2026-02-01
|
| Sarja: | Frontiers in Medicine |
| Aiheet: | |
| Linkit: | https://www.frontiersin.org/articles/10.3389/fmed.2026.1731378/full |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|